Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing potassium aminobenzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Potassium aminobenzoate 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Potassium aminobenzoate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Potassium chloride 1.5g/unt powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Potassium chloride 20meq powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
|
Potassium aminobenzoate 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Potassium aminobenzoate 500 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Potassium aminobenzoate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Potassium aminobenzoate 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Potassium aminobenzoate 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Potassium aminobenzoate 500 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing potassium aminobenzoate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing only potassium aminobenzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |
Product containing only potassium aminobenzoate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium aminobenzoate (substance) |
Inferred relationship |
Some |
1 |